A dual-action HIV antibody–drug conjugate forces Env to open, then blocks it, boosting virus neutralization up to tenfold in the lab.
Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences,” HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and ...
Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading innovation-driven ...
Researchers from Indian Institute of Science Education and Research (IISER) Mohali have discovered that unique antibodies from camels may help neutralise the dengue virus. Scientists say these tiny "n ...
NEW HAVEN, Conn., March 05, 2026 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD) today announced the appointment of Michael Mina, M.D., Ph.D., as Chief Medical Officer.
The Marblehead Board of Health is urging residents to review their vaccination histories following two recent measles cases reported in Massachusetts and continued seasonal respiratory illness ...
He spent 11 years as an "Eyewitness News" anchor, and later helmed local newscasts for the CBS and FOX-owned stations serving the New York market. He was also heard on the radio, at WABC-AM. Now, many ...
The Trump administration is curbing animal experiments in response to shifts in public opinion, technological advances, years ...
A 55-year-old man developed painful swelling that doctors later thought was arthritis. Subtle clues revealed something more ...
Health and Human Services Secretary Robert F. Kennedy Jr. revealed his agency will be cutting funding to mRNA development, calling the vaccine technology "ineffective" and claiming it poses more risks ...
An average of one baby a week in the Southern Health region is being given a preventive treatment after a potential measles ...
Virginia Tech researchers are advancing a new generation of vaccines designed to block opioids from reaching the brain and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results